Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Codexis Inc (NASDAQ: CDXS) closed at $2.67 up 1.52% from its previous closing price of $2.63. In other words, the price has increased by $1.52 from its previous closing price. On the day, 2.72 million shares were traded. CDXS stock price reached its highest trading level at $2.72 during the session, while it also had its lowest trading level at $2.61.
Ratios:
For a deeper understanding of Codexis Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.70 and its Current Ratio is at 5.82. In the meantime, Its Debt-to-Equity ratio is 1.24 whereas as Long-Term Debt/Eq ratio is at 1.19.
On May 30, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.Cantor Fitzgerald initiated its Overweight rating on May 30, 2024, with a $11 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 31 ’25 when Opaleye Management Inc. bought 84,220 shares for $2.68 per share. The transaction valued at 225,710 led to the insider holds 12,544,220 shares of the business.
Opaleye Management Inc. bought 780 shares of CDXS for $2,211 on Aug 04 ’25. The 10% Owner now owns 12,545,000 shares after completing the transaction at $2.83 per share. On Jul 29 ’25, another insider, Opaleye Management Inc., who serves as the 10% Owner of the company, bought 8,422 shares for $2.82 each. As a result, the insider paid 23,750 and bolstered with 12,458,422 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXS now has a Market Capitalization of 241014240 and an Enterprise Value of 243664128. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.22 while its Price-to-Book (P/B) ratio in mrq is 4.33. Its current Enterprise Value per Revenue stands at 4.263 whereas that against EBITDA is -4.661.
Stock Price History:
The Beta on a monthly basis for CDXS is 2.54, which has changed by -0.07931036 over the last 52 weeks, in comparison to a change of 0.1590569 over the same period for the S&P500. Over the past 52 weeks, CDXS has reached a high of $6.08, while it has fallen to a 52-week low of $1.90. The 50-Day Moving Average of the stock is -4.11%, while the 200-Day Moving Average is calculated to be -20.46%.
Shares Statistics:
For the past three months, CDXS has traded an average of 977.63K shares per day and 1696360 over the past ten days. A total of 90.25M shares are outstanding, with a floating share count of 87.50M. Insiders hold about 3.07% of the company’s shares, while institutions hold 79.85% stake in the company. Shares short for CDXS as of 1755216000 were 5189591 with a Short Ratio of 5.31, compared to 1752537600 on 5699514. Therefore, it implies a Short% of Shares Outstanding of 5189591 and a Short% of Float of 5.84.
Earnings Estimates
Investors are keenly observing as 3.0 analysts analyze and rate the current performance of Codexis Inc (CDXS) in the stock market.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.08 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.5 and -$0.68 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.62, with 2.0 analysts recommending between -$0.61 and -$0.63.
Revenue Estimates
A total of 7 analysts believe the company’s revenue will be $18.52M this quarter.It ranges from a high estimate of $20.2M to a low estimate of $16.27M. As of the current estimate, Codexis Inc’s year-ago sales were $12.83MFor the next quarter, 7 analysts are estimating revenue of $24.3M. There is a high estimate of $26.87M for the next quarter, whereas the lowest estimate is $22.21M.
A total of 7 analysts have provided revenue estimates for CDXS’s current fiscal year. The highest revenue estimate was $67.7M, while the lowest revenue estimate was $62.82M, resulting in an average revenue estimate of $65.66M. In the same quarter a year ago, actual revenue was $59.34MBased on 6 analysts’ estimates, the company’s revenue will be $79.88M in the next fiscal year. The high estimate is $87.6M and the low estimate is $75.5M.
